Johnson Kuo

ScinoPharm Taiwan, Ltd. is a Taiwan-based company principally engaged in the research and development, manufacture and distribution of bulk drugs. The Company's products include anastrozole, galantamine hydrobromide, azacitidine, gemcitabine hydrochloride, benazepril hydrochloride, granisetron hydrochloride, bimatoprost, irinotecan hydrochloride, letrozole, capecitabine, omeprazole, cladribine, ondansetron hydrochloride, dantrolene sodium, oxandrolone, oecitabine, paclitaxel and desmopressin acetate. The Company provides drug development service, chemical process development service, analytical chemistry service, current good manufacturing practice (cGMP) manufacturing service and other related technical services. The Company distributes its products within domestic market and to overseas markets.